Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

893 trials

NCT07693296
Recruiting
Type 2 Diabetes Mellitus and Downhill Aerobic Exercise Training
Not applicable · 1 site
Registry update: 9 Jul 2026
NCT07254689
Recruiting
The Food for Health Study
Not applicable · United States · 1 site
Registry update: 3 Apr 2026
NCT07478263
Recruiting
Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes
Not applicable · United States · 1 site
Registry update: 17 Mar 2026
NCT06695221
Recruiting
Improving Health Outcomes With Kefir
Not applicable · Canada · 1 site
Registry update: 8 May 2026
NCT07176793
Recruiting
Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
Not applicable · United States · 1 site
Registry update: 14 Sept 2026
NCT07351058
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Phase 3 · Argentina, Australia, Brazil, Canada, China, Czechia, Germany, Spain, France, United Kingdom, Hungary, India, Italy, Japan, South Korea, Mexico, Poland, Puerto Rico, Romania, Thailand, Türkiye, Taiwan, United States · 233 sites
Registry update: 9 Nov 2026
NCT07485075
Recruiting
Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
Not applicable · Denmark · 2 sites
Registry update: 20 Mar 2026
NCT07135531
Recruiting
Continuous Glucose Monitoring (CGM) in an Underserved Population
Not applicable · United States · 1 site
Registry update: 5 May 2026
NCT07466212
Recruiting
QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy
Not applicable · Denmark · 4 sites
Registry update: 22 Oct 2026
NCT07317115
Recruiting
Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
Not applicable · Canada · 1 site
Registry update: 19 May 2026
NCT07351045
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Phase 3 · Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, Germany, Spain, France, United Kingdom, Hungary, India, Italy, Japan, South Korea, Mexico, Netherlands, Poland, Taiwan, United States · 209 sites
Registry update: 9 Nov 2026
Conflicting statuses (updated in the registry within the last month)
NCT07457580
Recruiting
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Not applicable · Belgium, Germany, Spain, France, United Kingdom, Italy · 16 sites
Registry update: 9 Nov 2026
NCT07532863
Recruiting
A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants
Not applicable · Indonesia, Malaysia, Philippines, Singapore · 6 sites
Registry update: 28 Jul 2026
NCT07398300
Recruiting
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion
Not applicable · Denmark · 1 site
Registry update: 27 Oct 2026
NCT07061574
Recruiting
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Phase 1/2 · United States · 11 sites
Registry update: 16 Oct 2026
NCT06887049
Recruiting
Achieving Routine Intervention and Screening for Emotional Health
Not applicable · United States · 1 site
Registry update: 21 Oct 2026
NCT07416656
Recruiting
Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Not applicable · Denmark · 1 site
Registry update: 25 Jun 2026
NCT07359105
Recruiting
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
Not applicable · South Korea · 2 sites
Registry update: 10 Mar 2026
NCT06810635
Recruiting
Polyphenol Metabotypes in People With Diabetes Type 2
Not applicable · Belgium · 2 sites
Registry update: 23 Mar 2026
NCT07433192
Recruiting
POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.
Not applicable · Russia · 1 site
Registry update: 30 Apr 2026

Ordered by registry start date. Freshness and sponsorship never change the order.